Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study-Reference-Cited by-同舟云学术

Safety and immunogenicity of a high-dose quadrivalent influenza vaccine administered concomitantly with a third dose of the mRNA-1273 SARS-CoV-2 vaccine in adults aged ≥65 years: a phase 2, randomised, open-label study

Published:2022-04 Issue:4 Volume:10 Page:392-402
ISSN:2213-2600
Container-title:The Lancet Respiratory Medicine
language:en
Short-container-title:The Lancet Respiratory Medicine

Author:

Izikson Ruvim,Brune Daniel,Bolduc Jean-Sébastien,Bourron Pierre,Fournier Marion,Moore Tamala Mallett,Pandey Aseem,Perez Lucia,Sater Nessryne,Shrestha Anju,Wague Sophie,Samson Sandrine I

Funder

Sanofi Pasteur SA

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference34 articles.

1. Population risk factors for severe disease and mortality in COVID-19: a global systematic review and meta-analysis;Booth;PLoS One,2021

2. Comparative effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) vaccines in preventing COVID-19 hospitalizations among adults without immunocompromising conditions—United States, March–August 2021;Self;MMWR Morb Mortal Wkly Rep,2021

3. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data;Haas;Lancet,2021

4. Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study;Tartof;Lancet,2021

5. New COVID-19 cases and hospitalizations among adults, by vaccination status—New York, May 3–July 25, 2021;Rosenberg;MMWR Morb Mortal Wkly Rep,2021

Cited by 69 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenicity of concomitant SARS-CoV-2 and influenza vaccination in UK healthcare workers: a prospective longitudinal observational study;The Lancet Regional Health - Europe;2024-09

2. COVID-19 Vaccination Strategies in the Endemic Period: Lessons from Influenza;Vaccines;2024-05-09

3. Comparative effectiveness of the monovalent XBB.1.5-containing covid-19 mRNA vaccine across three Nordic countries;2024-05-09

4. Ipsilateral and contralateral coadministration of influenza and COVID-19 vaccines produce similar antibody responses;eBioMedicine;2024-05

5. Immunogenicity and safety of concomitant bivalent COVID-19 and quadrivalent influenza vaccination: implications of immune imprinting and interference;CLIN MICROBIOL INFEC;2024